screen-shot-2018-04-11-at-8-16-41-am-221x300-7645711As the legislative session heads into its closing weeks, it’s time to update Mandate Watch, the Empire Center’s tally of bills that would impose additional coverage requirements—and costs—on health plans.

The goal is to raise awareness of an expensive habit in Albany: passing insurance mandates without thinking through the consequences.

Most such bills mandate coverage for services that go beyond the evidence-based recommendations of medical societies and other experts—and might therefore encourage unnecessary or wasteful care. Almost all would tend to push up premiums that are already among the highest in the country. None has been subjected to rigorous cost-benefit analysis.

Since most large employers are self-insured, and therefore exempt from state regulation under federal law, mandates mostly affect the small-group and non-group markets—where buyers are more likely to drop coverage if premiums grow too quickly.

Our latest search of pending legislation, summarized here, turned up 120 proposals for new insurance mandates. That’s up 29, or almost one-third, since Mandate Watch was inaugurated in March 2017.

Most are one-house bills with little chance of becoming law. But six have passed the Assembly this year, and 25 have majority sponsors in both houses.

One of the more consequential bills—and probably the most expensive—is A. 2646 (Simotas)/S. 3148 (Savino), mandating coverage of in vitro fertilization (previously discussed in detail here). A similar law in Massachusetts adds an estimated $200 a year to the average cost of coverage for a family of four.

Other proposals include:

Some of these bills exceed mainstream guidelines. The American Cancer Society, for example, recommends mammograms for women at average risk starting at age 45, and says they should be optional at age 40.

The U.S. Preventive Services Task Force, meanwhile, urges biennial mammograms starting at age 50, and says they should be discretionary for women in their 40s.

By ignoring such guidelines, lawmakers run the risk of promoting unnecessary or even harmful procedures—and driving up premiums in the bargain.

To avoid such possibilities, the Legislature in 2007 voted to establish a commission to study the costs and benefits of proposed mandates before enacting them. Unfortunately, the officials responsible for appointing members of the panel never followed through, and Governor Cuomo vetoed its unused funding last year.

Looking to revive that good idea is Assemblyman Clifford Crouch (R-Bainbridge). He is sponsoring A. 2230, which would establish a Health Benefit and Cost Commission to review both existing mandates and new proposals.

“Many of the benefits mandated have served to ensure that people have access to care that they need, but this mandated coverage has also resulted in premium increases,” the sponsor’s memo says. “It is the sponsors’ belief that the Legislature and the public should have cost and benefit analysis before deciding whether to require all policies to include a certain benefit.”

About the Author

Bill Hammond

As the Empire Center’s director of health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

Hospitalization rising in some areas

Coronavirus hospitalizations are surging in parts of upstate, including three regions that the Cuomo administration authorized to begin reopening today. Read More

Uneven ‘relief’ for NY providers

A review of federal emergency payments to New York health-care providers reveals a striking disparity: Four of Manhattan's most prosperous private hospitals collected more individually than the 11 city-owned hospitals combined. Read More

A grim toll gets worse

The full toll of the coronavirus pandemic in New York is likely thousands higher than the official death tallies, according to newly released federal data. Read More

More fiscal turmoil for Medicaid

In a sign of pandemic-related strain on state finances, the Cuomo administration is postponing a series of multi-billion-dollar Medicaid payments over the next three months. Read More

Upstate escapes the worst

With the coronavirus pandemic hitting some parts of New York much harder than others, Governor Cuomo has signaled that he will begin to relax shutdown restrictions in low-virus parts of the state. Here's a closer look at how infection and fatality rates vary from region to region. Read More

Why New York?

#NYCoronavirus: It's increasingly apparent that New York is suffering more severely from the coronavirus pandemic than any other part of the U.S. and most of the rest of the world – raising stark questions for city and state leaders. What is it about New York, and especially New York City, that made it especially vulnerable to infection and death? And how can that be changed before the next virus breaks loose? Read More

Covid-19 testing rates vary by region

#NYCoronaVirus: Downstate New Yorkers are three times more likely than upstaters to have been tested for Covid-19 – and four times more likely to have been positive when checked. Read More

DOH posts age & county data

#NYCoronavirus: The state Health Department released additional coronavirus data that gives a clearer picture of which counties and age groups have been hardest hit by the pandemic so far. Read More

Subscribe

Sign up to receive updates about Empire Center research, news and events in your email.

CONTACT INFORMATION

Empire Center for Public Policy
30 South Pearl St.
Suite 1210
Albany, NY 12207

Phone: 518-434-3100
Fax: 518-434-3130
E-Mail: info@empirecenter.org

About

The Empire Center is an independent, non-partisan, non-profit think tank located in Albany, New York. Our mission is to make New York a better place to live and work by promoting public policy reforms grounded in free-market principles, personal responsibility, and the ideals of effective and accountable government.